RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial

Clinical trial NCT04625153 · TERMINATED

Trial details

NCT number: NCT04625153
Sponsor: RemeGen Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing-Remitting

Start date: 2021-05-13
Primary completion: 2026-04-03
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.